Abstract
The efficacy and tolerability of eribulin for advanced or metastatic breast cancer − a case series from the Norfolk and Norwich University Hospital NHS Foundation Trust, United Kingdom
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have